My understanding is SK is faster than HK. Yes there is certainly the possibility that SK or HK might treat the first patient. There is no real downside to this as ultimately we want to generate data that demonstrates that bisantrene is active in many different countries and populations. The broader the data, the more valuable (all things being equal).
- Forums
- ASX - By Stock
- Ann: RC220 GLP Non-clinical Toxicology Program Successful
My understanding is SK is faster than HK. Yes there is certainly...
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.83 |
Change
0.020(1.11%) |
Mkt cap ! $310.7M |
Open | High | Low | Value | Volume |
$1.81 | $1.83 | $1.79 | $142.0K | 78.77K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.83 | 641 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.810 |
3 | 7009 | 1.790 |
1 | 450 | 1.780 |
2 | 16392 | 1.770 |
2 | 1018 | 1.765 |
Price($) | Vol. | No. |
---|---|---|
1.830 | 558 | 1 |
1.840 | 4000 | 2 |
1.845 | 2746 | 1 |
1.860 | 1000 | 1 |
1.870 | 1200 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online